<link rel="stylesheet" href="styles.f3b1fba60ec7970c.css">

Publication:
Infection-related mortality after hematopoietic stem cell transplantation in a high antimicrobial resistance setting

Loading...
Thumbnail Image

Departments

School / College / Institute

Item type:Organizational Unit,
SCHOOL OF MEDICINE
Upper Org Unit
Item type:Organizational Unit,
Item type:Organizational Unit,

Program

Organization Authors

Co-Authors

İrkören, P.

Date

Language

eng

Embargo Status

N/A

Journal Title

Journal ISSN

Volume Title

Alternative Title

Abstract

Background Infectious complications remain a leading cause of mortality after hematopoietic stem cell transplantation (HSCT). We aimed to describe post-HSCT infections and their impact on survival in a center from a region with high antimicrobial resistance. Methods We included 522 patients with hematological malignancies undergoing HSCT at Koç University Hospital between 2016 and 2024. Bloodstream and opportunistic infections within 100 days were analyzed. Infection-related mortality (IRM) was defined as death primarily attributable to infectious complications. Predictors of 30- and 100-day mortality were assessed using multivariate logistic regression, including demographic and hematologic features, bloodstream infections (BSIs), invasive aspergillosis (IA), and cytomegalovirus reactivation. Results The most frequent diagnoses were non-Hodgkin lymphoma (36%), multiple myeloma (33%), and Hodgkin lymphoma (11%). Gram-negative bacteria (GNB) accounted for 73% of BSIs; Escherichia coli (31%) and Klebsiella pneumoniae (30%) were most frequent. Carbapenem resistance was highest in Klebsiella pneumoniae (67%), mainly due to OXA-48 carbapenemase (43%). Carbapenem-resistant Klebsiella pneumoniae (CRKP) bacteremia was associated with significantly reduced 100-day survival (log-rank p &lt; 0.001). IA also significantly impaired survival in the overall cohort (log-rank p &lt; 0.001). In the allogeneic subgroup ( n = 139), 100-day mortality reached 27%, with IA occurring in 19% and CRKP bacteremia in 17%. At 30 days, 25 patients (5%) had died; 24 of these deaths (96%) were attributed to infections. By day 100, 52 patients (10%) had died, and infections accounted for 42 deaths (80%). Conclusion In a high antimicrobial resistance setting, CRKP bacteremia and invasive aspergillosis were major determinants of early post-HSCT mortality. These findings highlight the need for optimized empirical therapy, antimicrobial stewardship, and strengthened infection prevention strategies in this vulnerable population.

Source

Publisher

Springer

Citation

item.page.haspartof

Source

European Journal of Clinical Microbiology and Infectious Diseases

item.page.ispartofseries

item.page.edition

DOI

10.1007/s10096-026-05481-w

item.page.datauri

item.page.link

Rights

N/A

Copyrights Note

Rights and licensing

Endorsement

Review

Supplemented By

Referenced By

Related Patent

Related Goal

Google Scholar
Scholar'da Ara ↗
0
Görüntülenme
0
İndirme
Altmetric
Dimensions
PlumX Metrikleri
BIP! Indicators